# Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection

> **NCT04458519** · NA · COMPLETED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 23 (actual)

## Conditions studied

- COVID-19 Infection

## Interventions

- **OTHER:** Probiorinse
- **OTHER:** Saline solution

## Key facts

- **NCT ID:** NCT04458519
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-16
- **Primary completion:** 2021-05-27
- **Final completion:** 2021-05-27
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2021-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04458519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04458519, "Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04458519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*